Low
₹51,179.81
High
₹51,644.88
Low
₹40,239.45
High
₹51,934.96
| Previous Close | ₹51,438.34 |
|---|---|
| Day's Range | ₹51,179.81 - ₹51,644.88 |
| Open | ₹51,207.38 |
| 52 Week Range | ₹40,239.45 - ₹51,934.96 |
| Volume | 1,44,58,809 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Ambalal Sarabhai Enterprises Ltd. | 40.45 | |
Healthcare |
| Cipla Ltd. | 1371.45 | |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1171.10 | |
Healthcare |
| Procter & Gamble Health Ltd. | 5520.00 | |
Healthcare |
| Lupin Ltd. | 2144.70 | |
Healthcare |
| Morepen Laboratories Ltd. | 120.90 | |
Healthcare |
| Torrent Pharmaceuticals Ltd. | 4804.25 | |
Healthcare |
| Abbott India Ltd. | 27309.10 | |
Healthcare |
| Glaxosmithkline Pharmaceuticals Ltd. | 2851.85 | |
Healthcare |
| Novartis India Ltd. | 2055.00 | |
Trading |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 23346.4 | 26373.20 | 22182.55 |
| Nifty IT | 28854.55 | 40301.40 | 25699.10 |
| Nifty Next 50 | 72025.4 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 8435.8 | 10443.40 | 8132.40 |
| Nifty Bank | 56358.7 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62191.25 | 64450.90 | 52032.85 |
| Nifty 500 | 22840.55 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17882.9 | 18500.95 | 14804.55 |
| Nifty 100 | 24498.75 | 26975.15 | 22720.45 |
| Nifty FMCG | 45466.8 | 57445.20 | 44825.60 |
Pursuant to Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, September 23, 2026 to consider the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions, subject to approval of the shareholders of the Company. Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Clause 9 of the Code for Prevention of Insider Trading in the securities of the Company, the company has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives from today i.e. September 19, 2026 till 48 hours after the declaration of outcome of Board Meeting. The trading window shall be opened with effect from September 26, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of index is ₹ as of .
The total volume of index is as of .
The percentage change in value of index is % as of .
The absolute increase in index value since the previous trading day is ₹ as of .
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.